KLRS · Kalaris Therapeutics, Inc.
Market Cap
$95.93M
Shares
23.80M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-07-17 | TH103 Ph 1a Data Presentation at American Society of Retina Specialists Annual Meeting 2026 | Shareholder meeting |
| 2025-12-17 | Phase 1a Data for TH103 in Treatment-Naïve Neovascular AMD Call | Webcast |
| 2025-12-03 | Noble Capital Markets 21st Annual Emerging Growth Equity Conference | Conference |
| 2025-11-13 | Stifel 2025 Annual Healthcare Conference | Conference |
| 2025-09-10 | Morgan Stanley 23rd Annual Global Healthcare Conference | Conference |
| 2025-06-05 | Noble Capital Markets 2025 Emerging Growth Virtual Equity Conference | Conference |
| 2025-05-27 | Stifel 2025 Virtual Ophthalmology Forum | Webcast |
| 2024-11-08 | AlloVir and Kalaris Therapeutics Merger Call | Webcast |
Source: https://investors.kalaristx.com/
Key facts
CIK
1754068
CUSIP
482929106
13F (30d)
53 filings
53 filers
Visit website
Investor relations